Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant

EMBO Journal

Volumn 15, Issue 4, 1996, Pages 827-838

  Rowan, Sheldon ^a,d   Ludwig, Robert L ^a   Haupt, Ygal ^b   Bates, Stewart ^a   Lu, Xin ^c   Oren, Moshe ^b   Vousden, Karen H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Apoptosis; G1 arrest; p53; Transcriptional activation; Tumor suppression

Indexed keywords

PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL CYCLE G1 PHASE; CELL DEATH; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSACTIVATION; TUMOR SUPPRESSOR GENE;

EID: 0030021748     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1460-2075.1996.tb00418.x     Document Type: Article

References (84)

1. 2/M when it is transactivation defective. EMBO J., 14, 4994-5005.
2. 2 arrest-dependent immunoglobulin κ light chain gene expression. EMBO J., 14, 1392-1401.
3. Baker, S.J., Markowitz, S., Fearon, E.R , Willson, J K V. and Vogelstein, B. (1990) Suppression of human colorectal carcinoma cell growth by wild-type p53. Science, 249, 912-915.
4. Barak, Y., Juven, T, Haffner, R. and Oren, M. (1993) mdm-2 expression is induced by wild type p53 activity. EMBO J., 12, 461-468.
5. Brugarolas, J., Chandrasekaran, C . Gordon, J I., Beach, D., Jacks, T. and Hannon, G.J. (1995) Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature, 377, 552-556.
6. Caelles, C., Helmberg, A. and Karin, M (1994) p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature, 370, 220-223.
7. Canman, C.E., Gilmer, T.M., Coutts, S.B. and Kastan, M.B. (1995) Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev., 9, 600-611.
8. Chen, J.D., Marechal, V. and Levine, A.J. (1993a) Mapping of the p53 and mdm-2 interaction domains. Mol. Cell. Biol., 13, 4107-1114.
9. Chen, J.Y., Funk, W.D., Wright, W.E., Shay, J.W. and Minna, J.D (1993b) Heterogeneity of transcriptional activity of mutant p53 protein and p53 DNA target sequences. Oncogene, 8, 2159-2166.
10. Cho, Y., Gorina, S., Jeffery, P.D. and Pavletich, N.P (1994) Crystal structure of a p53 tumor-suppressor-DNA complex: understanding tumorigenic mutations. Science, 265, 346-355.
11. Collins, M.K.L., Marvel, J., Malde, P. and Lopez-Rivas, A. (1992) Interleukin 3 protects murine bone marrow cells from apoptosis induced by DNA damaging agents. J. Exp. Med., 176, 1043-1051.
12. Cox, L.S., Hupp, T., Midgley, C.A. and Lane, D.P. (1995) A direct effect of activated human p53 on nuclear DNA replication. EMBO J., 14, 2099-2105.
13. Crook, T., Fisher, C. and Vousden, K.H. (1991) Modulation of immortalizing properties of human papillomavirus type 16 E7 by p53 expression. J. Virol, 65, 505-511.
14. Crook, T., Marston, N.J., Sara, E.A. and Vousden, K.H. (1994) Transcriptional activation by p53 correlates with suppression of growth but not transformation. Cell, 79, 817-827.
15. Cross, S.M., Sanchez, C.A., Morgan, C.A., Schimke, M.K., Ramel, S., Idzerda, R.L., Raskind, W.H. and Reid, B.J. (1995) A p53-dependent mouse spindle checkpoint. Science, 267, 1353-1356.
16. Debbas, M and White, E. (1993) Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev., 7, 546-554.
17. Demers, G.W., Foster, S.A., Halbert, C.L. and Galloway, D.A. (1994) Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7. Proc. Natl Acad. Sci. USA, 91, 4382-4386.
18. CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell, 82, 675-684.
19. Di Leonardo, A., Linke, S.P., Clarkin, K. and Wahl, G.M (1994) DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts Genes Dev., 8, 2540-2551.
20. Diller, L. et al. (1990) p53 functions as a cell cycle control protein in osteosarcomas. Mol Cell. Biol., 10, 5772-5781.
21. Donehower, L.A., Harvey, M., Slagle, B.L., McArthur, M.J., Montgomery, C.A ,Jr, Butel, J.S. and Bradley, A. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature, 356, 215-221
22. Dulic, V., Kaufmann, W.K., Wilson, S.J., Tlsty, T.D., Lees, E., Harper, J.W., Elledge, S.J. and Reed, S.I. (1994) p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell, 76, 1013-1023.
23. El-Deiry, W.S., Kern, S.E., Pietenpol, J.A., Kinzler, K.W. and Vogelstein, B. (1992) Definition of a consensus binding site for p53. Nature Genet., 1, 45-49.
24. El-Deiry, W. et al. (1993) WAF1, a potential mediator of p53 tumour suppression. Cell, 75, 817-825.
25. Fritsche, M., Haessler, C. and Brandner, G (1993) Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene, 8, 307-318.
26. Funk, W.D., Pak, D.T. Karas, R.H., Wright, W.E. and Shay, J.W. (1992) A transcriptionally active DNA-binding site for human p53 protein complexes Mol Cell. Biol., 12, 2866-2871.
27. Gottlieb, E., Haffner, R., von Ruden, T, Wagner, E.F. and Oren, M. (1994) Down-regulation of wild-type p53 activity interferes with apoptosis of IL-3 dependent hematopoietic cells following IL-3 withdrawal. EMBO J., 13, 1368-1374
28. Guillouf, C., Grana, X., Selvakumaran, M., De Luca, A., Giordano, A., Hoffman, B. and Liebermann, D.A. (1995) Dissection of the genetic programs of p53-mediated G1 growth arrest and apoptosis: blocking p53-induced apoptosis unmasks G1 arrest. Blood, 85, 2691-2698.
29. Harlow, E., Crawford, L.V., Pim, D.C. and Williamson, N.M. (1981) Monoclonal antibodies specific for simian virus 40 tumor antigens. J. Virol., 39, 861-869.
30. Haupt, Y., Rowan, S. and Oren, M. (1995a) p53-mediated apoptosis in HeLa cells can be overcome by excess pRB Oncogene, 10, 1563-1571.
31. Haupt, Y., Rowan, S., Shaulian, E., Vousden, K.H. and Oren, M. (1995b) Induction of apoptosis in HeLa cells by transactivation deficient p53. Genes Dev., 9, 2170-2183.
32. Hickman, E.S., Picksley, S.M. and Vousden, K.H. (1994) Cells expressing HPV16 E7 continue cell cycle progression following DNA damage induced p53 activation. Oncogene, 9, 2177-2181.
33. Hirano, Y., Yamato, K. and Tsuchida, N. (1995) A temperature sensitive mutant of the human p53, Val 138, arrests rat cell growth without inducing expression of cip1/waf1/sdi1 after temperature shift-down. Oncogene, 10, 1879-1885.
34. Hollstein, M. et al. (1994) Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res., 22, 3551-3555.
35. Howes, K.A., Ransom, L.N., Papermaster, D.S., Lasudry, J.G.H., Albert, D.M. and Windle, J.J. (1994) Apoptosis or retinoblastoma: Alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53. Genes Dev., 8, 1300-1310.
36. Ishioka, C., Englert, C., Winge, P., Yan, Y.-X., Engelstein, M. and Friend, S.H. (1995) Mutational analysis of the carboxy-terminal portion of p53 using both yeast and mammalian cell assays in vivo. Oncogene, 10, 1485-1492.
37. Jacks, T. Remington, L., Williams, B.O., Schmitt, E M., Halachmi, S., Bronson, R.T. and Weinberg, R.A (1994) Tumour spectrum analysis in p53-mutant mice. Curr. Biol., 4, 1-7.
38. Juven, T., Barak, Y., Zauberman, A., George, D.L. and Oren, M. (1993) Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene. Oncogene, 8, 3411-3416.
39. Kastan, M.B., Onyekwere, O., Sidransky, D., Vogelstein, B. and Craig, R.W. (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res , 51, 6304-6311.
40. Kastan, M.B. et al. (1992) A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell, 71, 587-597.
41. Kern, S., Kinzler, K., Bruskin, A., Jarosz, D., Friedman, P., Prives, C. and Vogelstein, B. (1991) Identification of p53 as a sequence specific DNA binding protein. Science, 252, 1708-1711.
42. Knudson, C.M., Tung, K.S.K., Tourtellotte, W.G., Brown, G.A.J. and Korsmeyer, S.J. (1995) Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science, 270, 96-98.
43. Kuerbitz, S.J., Plunkett, B.S., Walsh, W.V. and Kastan, M.B. (1992) Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl Acad Sci. USA, 89, 7491-7495.
44. Lam, E.W.F. and Waston, R.J. (1993) An E2F-binding site mediates cell-cycle regulation repression of mouse B-myb transcription. EMBO J., 12, 2705-2713.
45. Lane, D.P. (1992) p53, guardian of the genome. Nature, 358, 15-16.
46. Lane, D.P. (1994) The regulation of p53 function. Int. J. Cancer, 57, 623-627.
47. Lechner, M.S., Mack, D.H., Finicle, A.B., Crook, T., Vousden, K.H. and Laimins, L.A (1992) Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription. EMBO J., 11, 3045-3052.
48. Lin, D., Shields, M.T., Ullrich, S.J., Appella, E. and Mercer, W.E. (1992) Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase. Proc. Natl Acad. Sci. USA, 89, 9210-9214.
49. Livingstone, L.R., White, A., Sprouse, J., Livanos, E., Jacks, T. and Tlsty, T.D. (1992) Altered cell-cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell, 70, 923-935.
50. Lowe, S.W, Schmitt, E.M., Smith, S.W., Osborne, B.A. and Jacks, T. (1993) p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature, 362, 847-849.
51. Martinez, J., Georgoff, I. and Levine, A.J. (1991) Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes Dev., 5, 151-159
52. Mercer, W.E, Amim, M., Sauve, G.J., Appella, E., Ullrich, S.J and Romano, J W. (1990) Wild type human p53 is antiproliferative in SV40-transformed hamster cells. Oncogene, 5, 973-980.
53. Michalovitz, D., Halevy, O. and Oren, M (1990) Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell, 62, 671-680.
54. Miyashita, T. and Reed, J.C. (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 80, 293-299.
55. Miyashita, T. et al. (1994) Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene, 9, 1799-1805.
56. Okamoto, K. and Beach, D. (1994) Cyclin G is a transcriptional target of the p53 tumor-suppressor protein. EMBO J., 13, 4816-4822.
57. Oltvai, Z., Lilliman, C L. and Korsmeyer, S.J. (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death. Cell, 74, 609-619.
58. Oren, M. (1994) Relationship of p53 to the control of apoptotic cell death. Sem. Cancer Biol., 5, 3051-3057.
59. Ory, K., Legros, Y., Auguin, C. and Soussi, T. (1994) Analysis of the most representative tumour-derived p53 mutants reveals that changes in protein conformation are not correlated with loss of transactivation or inhibition of cell proliferation. EMBO J., 13, 3496-3504.
60. Owen-Schaub, L.B. et al. (1995) Wild-type human p53 and a temperature sensitive mutant induce Fas/APO-1 expression. Mol. Cell. Biol., 15, 3032-3040.
61. Pan, H.C. and Griep, A.E. (1994) Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: Implications for tumor-suppressor gene function in development. Genes Dev., 8, 1285-1299
62. Pietenpol, J.A., Tokino, T., Thiagalingam, S., El-Deiry, W., Kinzler, K.W. and Vogelstein, B. (1994) Sequence-specific transcriptional activation is essential for growth suppression by p53. Proc. Natl Acad. Sci. USA, 91, 1998-2002.
63. Pines, J. (1994) p21 inhibits cyclin shock. Nature, 369, 520-521.
64. Qin, X.-Q., Livingston, D.M., Kaelin, W.G. and Adams, P.D. (1994) Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl Acad. Sci. USA, 91, 10918-10922.
65. Sabbatini, P., Lin, J., Levine, A.J. and White, E. (1995) Essential role for p53-mediated transcription in apoptosis but not growth suppression. Genes Dev., 9, 2184-2192.
66. Shan, B. and Lee, W.H. (1994) Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis Mol. Cell. Biol., 14, 8166-8173.
67. Shaw, P., Bovey, R., Tardy, S., Sahli, R., Sordat, R. and Costa, J. (1992) Induction of apoptosis by wild type p53 in a human colon tumor-derived cell line. Proc. Natl Acad. Sci. USA, 89, 4495-4499.
68. Slebos, R.J.C. et al. (1994) p53-dependent G(1) arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc. Natl Acad. Sci. USA, 91, 5320-5324.
69. Stewart, N., Hicks, G.G., Paraskevas, F. and Mowat, M. (1995) Evidence for a second cell cycle block at G2/M by p53. Oncogene, 10, 109-115.
70. Symonds, H , Krall, L., Remington, L., Saenz-Robles, M., Lowe, S., Jacks, T. and Van Dyke, T. (1994) p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell, 78, 703-711.
71. Unger, T., Nau, M.M., Segal, S. and Minna, J.D. (1992) p53: a transdominant regulator of transcription whose function is ablated by mutations occurring in human cancer. EMBO J., 11, 1383-1390.
72. Unger, T., Mietz, J.A., Scheffner, M., Yee, C.L. and Howley, P.M. (1993) Functional domains of wild-type and mutant p53 proteins involved in transcriptional regulation, transdominant inhibition, and transformation suppression. Mol. Cell. Biol., 13, 5186-5194.
73. Vojtesek, B, Bartek, J., Midgley, C.A. and Lane, D.P. (1992) An immunochemical analysis of the human nuclear phosphoprotein p53. J. Immunol. Meth., 151, 237-244
74. Vousden, K.H. (1995) Regulation of the cell cycle by viral oncoproteins. Sem Cancer Biol., 6, 109-116.
75. waf1/cip1. Genes Dev., 8, 2817-2830.
76. Wu, X.W and Levine, A.J. (1994) p53 and E2F-1 cooperate to mediate apoptosis. Proc Natl Acad. Sci. USA, 91, 3602-3606.
77. Wu, X.W., Bayle, J.H., Olson, D and Levine, A.J. (1993) The p53 mdm-2 Autoregulatory Feedback Loop. Genes Dev., 7, 1126-1132.
78. Yin, Y., Tainsky, M.A., Bischoff, F.Z., Strong, L.C. and Wahl, G.M. (1992) Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell, 70, 937-948.
79. Yonish-Rouach, E., Resnitzky, D, Lotem, J., Sachs, L., Kimchi, A. and Oren, M. (1991) Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature, 353, 345-347.
80. Yonish-Rouach, E., Borde, J., Gotteland, M., Mishal, Z., Viron, A. and May, E. (1994) Induction of apoptosis by transiently transfected metabolically stable wt p53 in transformed cell lines. Cell Death Diff., 1, 39-47.
81. Zhan, Q., Fan, S., Bae, I., Guillouf, C., Liebermann, D.A., O'Connor, P.M. and Fornace, A.J. (1994) Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis. Oncogene, 9, 3743-3751.
82. Zhang, W., Funk, W.D., Wright, W.E., Shay, J.W and Deisseroth, A.B. (1994) A temperature sensitive mutant of human p53. EMBO J., 13, 2535-2544.
83. Zauberman, A., Barak, Y., Ragimov, N., Levy, N. and Oren, M. (1993) Sequence-specific DNA binding by p53 - identification of target sites and lack of binding to p53-MDM2 complexes. EMBO J., 12, 2799-2808
84. Zauberman, A., Lupo, A. and Oren, M. (1995) Identification of p53 target genes through immune selection of genomic DNA. the cyclin G gene contains two distinct p53 binding sites. Oncogene, 10, 2361-2366.